Views of a general population on mass screening for colorectal cancer: the Burgundy Study
- PMID: 1438107
- DOI: 10.1016/0091-7435(92)90065-p
Views of a general population on mass screening for colorectal cancer: the Burgundy Study
Abstract
Background: The success of a screening program depends on a number of factors, including the validity of the test, its efficacy, its feasibility, and the rate of compliance. Thus, it is important to determine the factors influencing compliance to the screening test in order to obtain a high participation rate.
Methods: A mass screening campaign for colorectal cancer using the Hemoccult test was conducted in Burgundy, France. One year later, a questionnaire was mailed to a random sample of the population to assess the views of the general public (870 persons who had not completed the Hemoccult test, 750 persons who had a negative test, and 100 persons who had a positive test). The compliance rate of this survey was 32.2% among persons who had not completed the screening test, 88.2% among persons with a negative result, and 98.0% among persons with a positive result.
Results: The main reason for not participating was not wanting to know more about their health status (34.3%). Of the factors credited with encouraging persons to perform the test, the most important ones were the practitioner's explanations (55.7%) and the leaflet sent by mail (42.5%). The impact of the media campaign was weak. A small portion of the population (4.3%) said that they were very anxious while waiting for the results. Among persons with a positive screening test, only 1.2% regretted having taken it. Among those who took the test, 94.2% said they were ready to do it again; and among those who did not take it, 36.7% would accept it at a second screening.
Conclusions: The data suggest that overall the Hemoccult is well accepted, that the campaign did not upset the population, and that it is worthwhile at the second screening to include those who did not participate in the first screening test.
Similar articles
-
Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.Eur J Cancer Prev. 1997 Feb;6(1):44-52. doi: 10.1097/00008469-199702000-00008. Eur J Cancer Prev. 1997. PMID: 9161812 Clinical Trial.
-
Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study.Eur J Cancer Prev. 1991 Oct;1(1):49-55. Eur J Cancer Prev. 1991. PMID: 1842684
-
[Preliminary results of a mass screening program for colorectal cancer].Gastroenterol Clin Biol. 1990;14(2):140-5. Gastroenterol Clin Biol. 1990. PMID: 2328881 French.
-
[Mass screening for colorectal cancer].Rev Epidemiol Sante Publique. 1996;44 Suppl 1:S7-14. Rev Epidemiol Sante Publique. 1996. PMID: 8935859 Review. French.
-
[Colorectal cancer screening: facts and questions].Gastroenterol Clin Biol. 2002 May;26(5 Suppl):B86-93. Gastroenterol Clin Biol. 2002. PMID: 12068275 Review. French. No abstract available.
Cited by
-
Colorectal Cancer Risk Perceptions Among Black Men in Florida.J Racial Ethn Health Disparities. 2024 Aug;11(4):1984-1993. doi: 10.1007/s40615-023-01667-6. Epub 2023 Jun 13. J Racial Ethn Health Disparities. 2024. PMID: 37311885
-
Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program.J Occup Environ Med. 2003 Aug;45(8):891-8. doi: 10.1097/01.jom.0000083038.56116.30. J Occup Environ Med. 2003. PMID: 12915791 Free PMC article.
-
Estimating the efficacy and efficiency of cascade genetic screening.Am J Hum Genet. 2001 Aug;69(2):361-70. doi: 10.1086/321973. Epub 2001 Jun 26. Am J Hum Genet. 2001. PMID: 11431707 Free PMC article.
-
Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.Am J Prev Med. 2014 Dec;47(6):703-14. doi: 10.1016/j.amepre.2014.08.005. Epub 2014 Nov 18. Am J Prev Med. 2014. PMID: 25455115 Free PMC article. Clinical Trial.
-
Randomized controlled dissemination study of community-to-clinic navigation to promote CRC screening: Study design and implications.Contemp Clin Trials. 2017 Feb;53:106-114. doi: 10.1016/j.cct.2016.12.006. Epub 2016 Dec 7. Contemp Clin Trials. 2017. PMID: 27940183 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical